A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions

Starting soon · Not applicable

Conditions studied: Skin Wounds, Abrasion

In brief

Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions

Key facts

Study ID

NCT07642973

Run by

Wooshin Labottach Co., Ltd.

People needed

40

Starts

2026-09-01

Expected to finish

2026-12-01

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female volunteers aged 18 to 64 years (inclusive).
• Informed consent form signed voluntarily before any study-related procedure.
• Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions.
• Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas).
• Agree to take precautions to prevent pregnancy (applicable only to non-menopausal women), including abstinence, intrauterine devices (IUDs), progestogen implants, combined estrogenic-progestogen contraceptives, the use of condoms;

You may not qualify if…

• Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices.
• History of keloid formation, hypertrophic scarring, or abnormal wound healing.
• Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities.
• History of diabetes mellitus, peripheral vascular disease, or arterial/venous microangiopathy.
• Systemic treatment with corticosteroids, immunosuppressive drugs, Anticoagulants, antiplatelet agents or cytostatic agents within 4 weeks prior to Baseline, or anticipated need during the study.
• Topical treatment (steroids, retinoids, antibiotics, or moisturizers) applied to the volar forearms within 2 weeks prior to Baseline.
• Active heavy smokers (more than 10 cigarettes per day) or users of nicotine-replacement therapies (nicotine alters cutaneous microcirculation and significantly impairs wound healing kinetics)
• Pregnant or lactating women, or women of childbearing potential not using highly effective contraception (see inclusion criteria).
• Not willing and able to comply with all study protocol requirements

Where it is running

• la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud — Monselice, PD, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.